Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) Director Robert Cascella acquired 50,000 shares of the firm’s stock in a transaction on Thursday, June 6th. The shares were bought at an average cost of $2.05 per share, with a total value of $102,500.00. Following the completion of the transaction, the director now directly owns 244,098 shares […]
Ocugen (NASDAQ:OCGN) Rating Reiterated by Chardan Capital dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Ocugen (NASDAQ:OCGN – Free Report) in a research report released on Wednesday, Benzinga reports. The firm currently has a $7.00 price objective on the stock. Separately, Chardan Capital boosted their price objective on shares of Ocugen from $4.00 to $5.00 and gave the company a buy […]
Chardan Capital Reaffirms Buy Rating for Ocugen (NASDAQ:OCGN) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Fielder Capital Group LLC bought a new stake in Neuronetics, Inc. (NASDAQ:STIM – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 22,797 shares of the company’s stock, valued at approximately $66,000. Fielder Capital Group LLC owned approximately 0.08% of Neuronetics at […]